Skip to main content

Animations

MJFF Publications

4131 - 4140 of 8404 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-020-00220-5
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Lack of evidence for association of UQCRC1 with Parkinson's disease in Europeans
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: The Emerging Role of the Lysosome in Parkinson’s Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9112399
    Citation Count: 74
  • Summary Details
    RESTRICTED
    Title: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8
    Citation Count: 283
  • Summary Details
    RESTRICTED
    Title: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice
    Journal Name: Molecular Biology
    Publisher: Pleiades Publishing Ltd
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1134/s0026893320060060
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Estimation of Orofacial Kinematics in Parkinson’s Disease: Comparison of 2D and 3D Markerless Systems for Motion Tracking
    Journal Name: 2020 15th IEEE International Conference on Automatic Face and Gesture Recognition (FG 2020)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/fg47880.2020.00112
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Hitting the Bullseye: Are extracellular vesicles on target?
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/jev2.12032
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Pharmaceutical Implications of Sex-Related RNA Divergence in Psychiatric Disorders
    Journal Name: Trends in Pharmacological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tips.2020.09.003
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Preferential microglial activation associated with pathological alpha synuclein transmission
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2020.09.027
    Best OA location URL:
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.